News | News By Subject | News by Disease News By Date | Search News

Diabetes, Type 2 (non-insulin dependent) News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Alphabet's Verily, Sanofi (SNY) Launch $500 Million Onduo, Joint Venture to Open New HQ in Kendall Square     9/13/2016
With Hopes of Bolstering Sanofi (SNY)’s Sagging Diabetes Sector, Announces FDA Approval of Adlyxin in U.S.     7/28/2016
FDA Panel Narrowly Backs Cardiovascular Claims for Boehringer Ingelheim, Eli Lilly (LLY)'s Jardiance     6/29/2016
Sanofi (SNY)'s New Diabetes Combo Nails Late-Stage Goals     6/13/2016
Sanofi (SNY) Snags FDA Panel's Support for New Once-Daily Diabetes Combo iGlarLixi     5/26/2016
Oramed (ORMP)'s Oral Insulin Succeeds In Phase IIb Type 2 Diabetes Trial     5/18/2016
Intarcia Touts Large Phase III Trial Diabetes Data, Bags $75 Million     5/6/2016
Eli Lilly (LLY) Abandons Development of Transition Therapeutics (TTH.TO)' Diabetes Candidate TT401     4/19/2016
Sanofi (SNY) Pays $20 Million Milestone and Redeems Priority Review Voucher for Zealand Pharma  (ZEAL.CO)’s LixiLan     12/23/2015
FDA Clears Eli Lilly (LLY)'s Diabetes Drug Basaglar     12/17/2015
Biodel (BIOD) Announces Removal of Partial FDA Clinical Hold on Phase IIb Study 3-250     10/12/2015
SoCal's Elcelyx Therapeutics Reels in $40 Million     10/1/2015
Novo Nordisk A/S (NVO) Finally Bags Diabetes Drug Tresiba U.S. Approval     9/28/2015
Novartis AG (NVS) Launches New Portfolio Of Affordable Medicines for Poor Countries     9/24/2015
Merck & Co. (MRK)'s Once-Weekly Diabetes Drug Works Same as Januvia; Drugmaker Plans to File Drug by End of 2015     9/17/2015

News from Around the Web
Long Naps Linked To Diabetes, University of Tokyo Study     9/15/2016
Early And Late Menopause Can Increase Risk Of Type 2 Diabetes, Kaiser Permanente Study     7/27/2016
Cycling May Help Lower Type 2 Diabetes Risk, University Of Southern Denmark Study     7/13/2016
Sex Could Play A Role In Type 2 Diabetes Treatment... But Not In The Way You Think, IRCM Study     7/6/2016
Gray Matter Changes In Brains Of Teenagers With Type 2 Diabetes, Cincinnati Children's Hospital Medical Center Scientists Reveal     6/15/2016
GI Windows Anastomosis System For Treating Type 2 Diabetes     6/2/2016
Eating Junk Food Just As Harmful To Kidneys As Diabetes, Anglia Ruskin University Study     5/10/2016
More Blood Vessels In Adipose Tissue May Alleviate Type 2 Diabetes, University of Helsinki Study     4/25/2016
How Depression May Boost Your Type 2 Diabetes Risk, McGill University Study     4/15/2016
Long Naps, Daytime Sleepiness Tied To Heart Risks, University of Tokyo Reveals     3/28/2016
Thirdhand Smoke Doubles Your Diabetes Risk, University of California, Riverside Study     3/3/2016
Molecular Link Between Psychiatric Disorders And Type 2 Diabetes Discovered, University of Massachusetts Medical School Scientists Reveal     2/8/2016
Every Hour Spent On The Couch Ups Your Diabetes Risk By 22%, Maastricht University Research Shows     2/3/2016
New Findings May Reveal Why Type 2 Diabetics Experience Smelling Problems, Karolinska Institute Study     1/21/2016
Eating Potatoes On A Regular Basis May Up Risk Of T2DM, Osaka Center For Cancer And Cardiovascular Disease Prevention Study     12/31/2015

Press Releases
Voluntis Wins FDA Clearance and CE Mark for Diabetes Management App, Insulia     12/6/2016
Boehringer Ingelheim Release: FDA Approves Jardiance To Reduce Cardiovascular Death In Adults With Type 2 Diabetes     12/5/2016
Novo Nordisk A/S (NVO) Files For Regulatory Approval Of Once-Weekly Semaglutide With The FDA For The Treatment Of Type 2 Diabetes     12/5/2016
Oramed (ORMP)'s ORMD-0901 (Oral GLP-1 Analog) Found Safe And Well Tolerated In Phase Ib Study     11/29/2016
Novo Nordisk A/S (NVO) Receives FDA Approval For Xultophy 100/3.6 (Insulin Degludec And Liraglutide Injection)     11/22/2016
Sanofi (SNY) Receives FDA Approval Of Soliqua 100/33 For The Treatment Of Adults With Type 2 Diabetes     11/22/2016
Zealand Pharma  (ZEAL.CO) Release: The U.S. FDA Approves Soliqua 100/33 For The Treatment Of Adults With Type 2 Diabetes     11/22/2016
Boehringer Ingelheim Release: Survey Reveals Most People Don't Know Heart Disease Is The No. 1 Killer Of People With Type 2 Diabetes     11/22/2016
Intarcia Submits New Drug Application (NDA) To FDA For U.S. Marketing Approval Of ITCA 650 In Type 2 Diabetes     11/21/2016
ProMetic Life Sci (PFSCF.PK) Receives Clearance From Health Canada To Proceed With Its PBI-4050 Placebo-Controlled Phase 2 Clinical Trial In Patients With Metabolic Syndrome And Type 2 Diabetes     11/16/2016
Eli Lilly (LLY) Release: Jardiance (Empagliflozin) Consistently Reduced The Risk Of Cardiovascular Death In Adults With Type 2 Diabetes Regardless Of The Type Of Cardiovascular Disease At Baseline     11/14/2016
Zealand Pharma  (ZEAL.CO) Release: CHMP Issues Positive Opinion Recommending Suliqua (Iglarlixi) For Approval In The EU     11/11/2016
Fractyl Presents New Revita DMR Liver Data In Type 2 Diabetes At American Association for Study of Liver Diseases 2016     11/11/2016
GI Dynamics (GID.AX) Release: German Registry Releases Positive EndoBarrier Data At EASD     11/9/2016
Mylan (MYL) And BioCon (BIOCON.NS) Announce Regulatory Submission For Insulin Glargine Accepted For Review By EMA     11/3/2016

//-->